| Annual Financials | 2022 | 2023 | TTM |
Revenue  | 148 | 207 | 0 |
| Expenses | 129 | 159 | 0 |
| EBITDA | 20 | 48 | 0 |
| Operating Profit % | 12 % | 22 % | 0 % |
| Depreciation | 3 | 3 | 0 |
| Interest | 1 | 1 | 0 |
| Profit Before Tax | 15 | 44 | 0 |
| Tax | 4 | 11 | 0 |
| Net Profit | 11 | 34 | 0 |
| EPS in ₹ | 11.11 | 24.84 | 0.00 |
Jeena Sikho Lifecare
Jeena Sikho Lifecare
702.95
-13.10
(-1.83%)
Key Fundamentals
Market Cap
8,737.72 Cr
EPS
24.84
PE Ratio
263.14
Dividend Yield
0.15 %
Industry
Healthcare 52 Week High
2,498.60
52 Week Low
400.25
PB Ratio
70.72
Debt to Equity
0.05
Sector
Pharmaceuticals Actual
Company News
View All News
Jeena Sikho Lifecare Limited reported strong quarterly results with revenue from operations reaching Rs. 190 crores in Q2FY26, marking a 66% year-on-year growth from Rs. 114 crores in Q2FY25 and 9% quarter-over-quarter growth from Rs. 174 crores in Q1FY26. The company's profit after tax surged 121% year-on-year to Rs. 59 crores, with a 15% quarter-over-quarter increase. EBITDA grew 129% year-on-year to Rs. 92 crores, maintaining a strong margin of 48%. The healthcare provider expanded its bed capacity by 582 beds, reaching a total of 2,802 beds with 57% occupancy rate across 58 hospitals and 59 clinics. The company operates in 23 states and 100+ cities. Jeena Sikho announced a strategic partnership with Chandan Diagnostic, providing access to 40 lakh privilege cardholders and establishing diagnostic centers across their network. The company is launching 10 new OTC products by year-end and has tied up with Salesforce for improved data management and customer engagement.
Jeena Sikho Lifecare Expands Bed Capacity to 2,220 and Reports Strong Growth Across Services
Nov 06, 2025
Nov 06, 2025Jeena Sikho Lifecare has increased its bed capacity to 2,220 with an additional 400 beds under development. The company reported significant growth in outpatient services (+67%), inpatient services (+57%), and daycare services (+169%). The company is focusing on the high-margin private sector and plans to launch 6 new Ayurvedic products. It is enhancing its digital infrastructure through a Salesforce partnership. The company maintains a 71% ROCE and has achieved a 47% three-year CAGR. It operates 46 NABH-accredited centres and aims to expand its Ayurvedic healthcare network nationwide using an asset-light strategy and AI efficiency.
Jeena Sikho Lifecare delivered robust quarterly results with net profit surging to 588 million rupees from 266 million rupees year-over-year, representing a 121% increase. Revenue grew significantly to 1.9 billion rupees compared to 1.14 billion rupees in the same period last year, marking a 67% growth. EBITDA more than doubled to 921 million rupees from 403 million rupees year-over-year. The company's EBITDA margin expanded substantially to 48.49% from 35.30% in the previous year, indicating improved operational efficiency and profitability.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,781.70 | #1 4,27,489.51 | 40.68 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 71.49 | |
6,391.50 | 1,69,674.24 | 69.05 | 9,712.00 | 18.67 | 2,191 | 35.10 | 47.34 | |
3,687.30 | 1,24,794.99 | 58.80 | 11,539.40 | 6.99 | 1,911 | 30.46 | 54.89 | |
1,517.20 | 1,22,552.45 | 22.73 | 28,409.50 | 7.12 | 5,291 | 3.71 | 48.01 | |
1,247.20 | 1,04,093.03 | #1 18.15 | 33,741.20 | 16.73 | 5,725 | -0.38 | 53.56 | |
926.25 | 93,202.42 | 18.56 | 23,511.00 | 18.55 | 4,615 | 34.60 | 33.23 | |
2,032.00 | 92,812.52 | 21.34 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 58.77 | |
2,241.70 | 92,528.07 | 52.05 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 32.96 | |
1,210.10 | 70,282.80 | 20.70 | 32,345.60 | 9.43 | 3,484 | 3.81 | 63.26 | |
5,693.00 | 68,068.35 | 28.29 | 13,458.30 | 3.70 | 2,216 | 10.98 | 60.35 |
Growth Rate
Revenue Growth
40.07 %
Net Income Growth
199.11 %
Cash Flow Change
-11.19 %
ROE
-13.14 %
ROCE
-17.44 %
EBITDA Margin (Avg.)
76.14 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2025 |
| Total Assets | 62 | 151 | 419 |
| Fixed Assets | 29 | 60 | 208 |
| Current Assets | 22 | 78 | 136 |
| Capital Work in Progress | 5 | 1 | 11 |
| Investments | 0 | 5 | 12 |
| Other Assets | 28 | 86 | 0 |
| Total Liabilities | 62 | 151 | 419 |
| Current Liabilities | 24 | 25 | 73 |
| Non Current Liabilities | 1 | 1 | 89 |
| Total Equity | 37 | 126 | 256 |
| Reserve & Surplus | 26 | 112 | 232 |
| Share Capital | 10 | 14 | 25 |
Cash Flow
| Cash Flow | 2022 | 2023 |
| Net Cash Flow | -7 | 29 |
| Investing Activities | -19 | -33 |
| Operating Activities | 16 | 15 |
| Financing Activities | -5 | 48 |
Share Holding
| % Holding | Sept 2021 | Feb 2022 | Apr 2022 | Sept 2022 | Mar 2023 | Sept 2023 | Nov 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Aug 2025 | Sept 2025 |
| Promoter | 90.00 % | 90.00 % | 65.89 % | 65.89 % | 66.20 % | 67.91 % | 67.91 % | 67.91 % | 65.84 % | 63.53 % | 63.53 % | 63.53 % | 63.61 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 5.99 % | 6.59 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.18 % | 0.15 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 10.00 % | 10.00 % | 20.05 % | 16.21 % | 15.28 % | 14.41 % | 14.94 % | 17.34 % | 16.72 % | 16.67 % | 17.05 % | 17.20 % | 17.32 % |
| Others | 0.00 % | 0.00 % | 14.06 % | 17.90 % | 18.52 % | 17.68 % | 17.15 % | 14.75 % | 17.44 % | 19.80 % | 19.41 % | 13.10 % | 12.33 % |
| No of Share Holders | 7 | 6 | 1,951 | 834 | 663 | 814 | 1,107 | 2,721 | 3,423 | 5,967 | 6,603 | 7,434 | 16,362 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.47 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.76 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Aug 2023 |  Dividend | ₹ 2.00 /share | 25 Aug 2023 | 333.00 | 1,065.05 |
| 02 Nov 2023 |  Bonus | 4:5 | 02 Nov 2023 | 1,195.50 | 1,403.25 |
| 27 Feb 2024 |  Extraordinary General Meeting | NA | 27 Feb 2024 | 641.00 | 857.80 |
| 20 Aug 2024 | Dividend | ₹ 4.18 /share | 20 Aug 2024 | 1,121.40 | 1,416.40 |
| 28 Aug 2024 |  Annual General Meeting | NA | 28 Aug 2024 | 1,147.00 | 1,351.20 |
| 11 Nov 2024 |  Quarterly Result Announcement | NA | 11 Nov 2024 | 1,723.10 | 1,706.30 |
| 16 May 2025 | Quarterly Result Announcement | NA | 16 May 2025 | 2,284.55 | 2,353.90 |
| 21 Apr 2025 |  Split | 2:10 | 12 Jun 2025 | 2,251.25 | 2,251.25 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 547.35 | 560.70 |
| 22 Sept 2025 | Dividend | ₹ 1.10 /share | 22 Sept 2025 | 2,353.90 | 816.20 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 702.30 | 802.15 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 742.00 | 782.60 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript8 days ago
8 days agoEmpanelment Of Jeena Sikho Lifecare Limited Ayurveda Panchkarma Hospital With Maruti Suzuki India Limited For Providing Cashless Ayurveda Panchkarma Treatment10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Nov 06, 2025Appointment Of M/S Deepak K Garg & Associates As The Internal Auditors For FY 2025-26Nov 06, 2025
Nov 06, 2025Results-Financial Results For Quarter Ended 30Th September 2025Nov 06, 2025
Nov 06, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 06Th November 2025Nov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2025
Nov 05, 2025Board Meeting Intimation for Prior Intimation And Trading Window Closure Of The Board Meeting To Be Held On November 06 2025.Nov 03, 2025
Nov 03, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 14, 2025
Oct 14, 2025Additional Information Regarding Corporate Announcement For Outcome Of Board Meeting Dated 13Th October 2025Oct 14, 2025
Oct 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th October 2025Oct 13, 2025
Oct 13, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Commencement Of Operations Of New Hospital In Raigad District MaharashtraSep 24, 2025
Sep 24, 2025Intimation Regarding Conferment Of Grand Records Honorary CertificateSep 22, 2025
Sep 22, 2025Intimation Of Receiving The 6Th National Atal Award 2025 In The Category Of Indian Ayurveda.Sep 22, 2025
Sep 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 18, 2025
Sep 18, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 12, 2025
Sep 12, 2025Intimation Under Regulation 30 Of SEBI (LODR) - Collaboration With Salesforce For Digital Transformation In Ayurvedic HealthcareSep 12, 2025
Sep 12, 2025Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - Commencement Of Operations Of New Hospital At JammuSep 12, 2025
Sep 12, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Approval Of Clinical Trial Of Anti-Diabetes Efficacy Of SDM02 TABLETS Shuddhi XS Syrup Petshuddhi Churna And Shuddhi Dr. B P Care Tablets.Sep 08, 2025
Sep 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2025
Sep 06, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Publication Of Case Studies And Reports.Sep 05, 2025
Sep 05, 2025Proposal For Establishment Of New Branch Of Jeena Sikho Lifecare Limited Hospital In Bhagalpur BiharSep 04, 2025
Sep 04, 2025Empanelment Of Jeena Sikho Lifecare Limited Ayurveda Panchkarma Hospital With GIPSA For Providing Cashless Ayurveda Panchkarma Treatment.Sep 04, 2025
Sep 04, 2025Reg. 34 (1) Annual Report.Sep 03, 2025
Sep 03, 2025Weblink For Notice Of 8Th Annual General Meeting And Annual Report For The Financial Year 2024-25Sep 03, 2025
Sep 03, 2025Business Responsibility and Sustainability Reporting (BRSR)Sep 03, 2025
Sep 03, 2025Notice Of The 8Th Annual General Meeting And Integrated Annual Report For Financial Year 2024-25Sep 03, 2025
Sep 03, 2025Intimation Of Record Date For Final Dividend Under Regulation 42 Of SEBI (LODR) Regulations 2015.Aug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2025
Aug 28, 2025Publication Of Case StudiesAug 28, 2025
Aug 28, 2025The Board At Its Meeting Held On 27Th August 2025 Decided To Hold The 8Th Annual General Meeting Of The Company On Monday 29Th September 2025 At 12:00 Noon.Aug 27, 2025
Aug 27, 2025Book Closure Of The Register Of Members And Share Transfer Books Of The Company From Tuesday September 23 2025 To Monday September 29 2025 (Both Days Inclusive) For The 8Th Annual General Meeting.Aug 27, 2025
Aug 27, 2025Approval Of Jeena Sikho Lifecare Limited Employee Stock Option Scheme 2025Aug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 27, 2025
Aug 27, 2025Fixation Of Dividend Record DateAug 27, 2025
Aug 27, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 27Th August 2025Aug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 23, 2025
Aug 23, 2025Board Meeting Intimation for 1. To Consider And Approve The Proposal For Employee Stock Option Scheme 2025 In Terms Of SEBI (Share Based Employee Benefits And Sweat Equity) Regulations 2021.
2. To Consider Any Other Matter With The Permission Of The ChaiAug 23, 2025
Aug 23, 2025Empanelment Of Jeena Sikho Lifecare Limited-Vaishali (Ghaziabad) Gurugram Delhi & Meerut Branches Under CBSE.Aug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 21, 2025
Aug 21, 2025Intimation Of NABH Certification For Jeena Sikho Lifecare Limited (Hospital)- Agra And Panchkula BranchAug 19, 2025
Aug 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 19, 2025
Aug 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 18, 2025
Aug 18, 2025Technical Indicators
RSI(14)
Neutral 43.08
ATR(14)
Less Volatile 32.32
STOCH(9,6)
Oversold 10.89
STOCH RSI(14)
Oversold 8.86
MACD(12,26)
Bearish -4.60
ADX(14)
Weak Trend 14.07
UO(9)
Bearish 38.12
ROC(12)
Downtrend And Accelerating -7.30
WillR(14)
Oversold -89.44
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
